Results for tag: "Chikungunya Drug"

The Chikungunya Drug market is a subset of the larger Infectious Diseases Drugs market. Chikungunya is a mosquito-borne virus that causes fever, joint pain, and rash. There is currently no specific treatment or vaccine for the virus, but there are drugs available to help manage the symptoms. These drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and analgesics. Additionally, supportive care such as rest, fluids, and fever-reducing medications may be recommended. The Chikungunya Drug market is highly competitive, with many companies offering products to treat the virus. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Additionally, there are many smaller companies that offer products to treat the virus, such as Cipla, Sun Pharmaceuticals, and Lupin. Show Less Read more